Cargando…
Aberrant ADAM10 expression correlates with osteosarcoma progression
BACKGROUND: Osteosarcoma is the most common type of bone cancer and is notorious for its rapid progression. The Notch signaling pathway has recently been shown to be involved in osteosarcoma. As a major sheddase of Notch receptors, ADAM10 has been implicated in many types of cancers, but its role in...
Autores principales: | Zhao, Ren, Ni, Dongjing, Tian, Yi, Ni, Bing, Wang, Aimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936952/ https://www.ncbi.nlm.nih.gov/pubmed/24548763 http://dx.doi.org/10.1186/2047-783X-19-9 |
Ejemplares similares
-
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice
por: Prinzen, Claudia, et al.
Publicado: (2009) -
Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma
por: Zhao, Jiali, et al.
Publicado: (2016) -
Aberrant expression of ADAM9 in ovarian cancer and its clinical significance
por: Guo, Ting, et al.
Publicado: (2019) -
Differential Surface Expression of ADAM10 and ADAM17 on Human T Lymphocytes and Tumor Cells
por: Ebsen, Henriette, et al.
Publicado: (2013) -
Aberrant CXCR4 and β-catenin expression in osteosarcoma correlates with patient survival
por: LU, YAO, et al.
Publicado: (2015)